{
    "clinical_study": {
        "@rank": "154724", 
        "arm_group": [
            {
                "arm_group_label": "MariGen Wound", 
                "arm_group_type": "Active Comparator", 
                "description": "Fish derived extra cellular matrix"
            }, 
            {
                "arm_group_label": "Oasis Sheet", 
                "arm_group_type": "Active Comparator", 
                "description": "Pig intestine derived extra cellular matrix"
            }
        ], 
        "brief_summary": {
            "textblock": "The objective is to determine, if healing of punch biopsy wounds treated with the fish skin\n      derived MariGen Wound dressing is non-inferior to healing with wounds treated with pig\n      intestines derived Oasis Sheet wound dressing. Secondary endpoints are: Incidence of\n      erythema, Pain, Infection, Quantitative measurements of autoantibodies at baseline and 4\n      weeks after start of treatment"
        }, 
        "brief_title": "Healing of Punch Graft Wounds. Comparative Study Between MariGen and Oasis: a Non-inferiority Study", 
        "completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "condition": [
            "Punch Biopsy Wounds", 
            "Healing Times"
        ], 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  >18 yrs\n\n          -  Healthy individual\n\n          -  Signature of informed consent\n\n        Exclusion Criteria:\n\n          -  Autoimmune disease\n\n          -  Immunosuppressive treatment\n\n          -  Use of addictive drugs\n\n          -  Excessive use of alcohol\n\n          -  Known fish allergy\n\n          -  Known allergy to proteins with porcine origin\n\n          -  Peripheral vascular disease\n\n          -  Pregnant women\n\n          -  Persons receiving anticoagulation therapy or systemic corticosteroids will be\n             excluded."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "81", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "July 29, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01917591", 
            "org_study_id": "KS-0070"
        }, 
        "intervention": [
            {
                "arm_group_label": "MariGen Wound", 
                "description": "Weekly dressing changes and review of wounds.", 
                "intervention_name": "Punch biopsies treated with MariGen Wound ECM dressing", 
                "intervention_type": "Device", 
                "other_name": "MariGen Wound ECM wound dressings."
            }, 
            {
                "arm_group_label": "Oasis Sheet", 
                "description": "Weekly dressing changes and wound review", 
                "intervention_name": "Punch biopsies treated with Oasis ECM dressing", 
                "intervention_type": "Device", 
                "other_name": "Oasis ECM wound dressing"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Bandages", 
            "Biological Dressings", 
            "Chronic Disease", 
            "Collagen", 
            "Epithelium", 
            "Extracellular Matrix", 
            "Extra Cellular Matrix", 
            "Fibroblasts", 
            "Granulation Tissue", 
            "Leg Ulcer", 
            "Middle Aged", 
            "Prospective Studies", 
            "Soft Tissue Injuries", 
            "Treatment Outcome", 
            "Varicose Ulcer", 
            "Wound Healing", 
            "Wounds and Injuries", 
            "biopsy", 
            "autoimmunity"
        ], 
        "lastchanged_date": "August 5, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Reykjavik", 
                    "country": "Iceland", 
                    "zip": "105"
                }, 
                "name": "L\u00e6knastofur Skipholti"
            }
        }, 
        "location_countries": {
            "country": "Iceland"
        }, 
        "number_of_arms": "2", 
        "official_title": "Healing of Punch Graft Wounds With Two Biologic Exracellular Matrices; a Non-inferiority Study", 
        "overall_official": {
            "affiliation": "The National University Hospital of Iceland", 
            "last_name": "Hugrun Thorsteinsdottir, MD Derm", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Iceland: Ministry of Health and Social Security", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "wound healing", 
            "safety_issue": "No", 
            "time_frame": "28 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01917591"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Measurement of auto-antibodies including anti-collagen I and II antibodies", 
                "measure": "Autoimmune investigations", 
                "safety_issue": "Yes", 
                "time_frame": "28 days"
            }, 
            {
                "measure": "Incidence of erythema", 
                "safety_issue": "No", 
                "time_frame": "28 days"
            }, 
            {
                "measure": "Pain", 
                "safety_issue": "Yes", 
                "time_frame": "28 days"
            }, 
            {
                "measure": "Infection", 
                "safety_issue": "Yes", 
                "time_frame": "28 days"
            }
        ], 
        "source": "Kerecis Ltd.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Kerecis Ltd.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}